NCT01398397

Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 11 (actual)
• Sponsor: Edimer Pharmaceuticals · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is being done to collect information about people who have or may have Hypohidrotic Ectodermal Dysplasia (HED) or X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). This study will allow Edimer Pharmaceuticals to know more about HED/XLHED so that hopefully the investigators can develop a drug to treat this condition. In this study Edimer will retrospectively review and abstract (summarize) medical records of people that have or may have HED/XLHED in order to further understand the natural history and disease characteristics.

Conditions

• Hypohidrotic Ectodermal Dysplasia
• X-Linked Hypohidrotic Ectodermal Dysplasia

Timeline

• Start date: 2011-04-01
• First posted: 2011-07-20
• Last updated: 2012-06-28

Locations

1 site across 1 country: United States